ARCHIVES

NTP Board Considers Modification Of Human Risk Statement, Adopts Plan For Chemical Selection

This article is from The Cancer Letter archive.

Vol. 06 No. 44 | November 7, 1980

Download PDF Visit The Full Archive

Related Articles

Rabson’s Group Hears Suggestions On Carcinogenesis

November 25, 1977

FDA News: Tentative Approval Given IVAX Paxene; BMS Exclusivity Upheld

January 9, 1998

NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions.

December 12, 2003

Nexavar Phase III Trial Fails To Meet Primary Endpoint

June 29, 2012

NCI-Approved Clinical Trials Listed For April 2001

May 25, 2001

In Brief: Three, Perhaps Four May Be Recommended To Carter; Hugh Creech To Retire July 1

April 1, 1977